Celtic plc (CCPA)
London Exchange · UK · prices in GBX · close of 21 Oct 2026
Key indicators
| Last close | GBX 209.00 |
|---|---|
| 52-week range | 169.97 – 255.96 |
| Return, 1 month / 3 months | −4.6% / −7.9% |
| Return, 1 year / 3 years | +14.5% / +60.2% |
| Trend | Below its 200-day average |
| RSI (14) | 1 |
| Volatility (1 year) | 16.3% |
| Worst drawdown (1 year) | -16.7% |
| Average daily value traded | 0.11M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Celtic plc is the company behind Celtic Football Club, a professional football team based in Glasgow, Scotland. The club fields a men's team that competes in the Scottish league system and plays its home matches at Celtic Park. Alongside the football operation, the company runs related commercial activities, including merchandising for supporters and hospitality at its stadium, serving fans and visitors in Scotland and beyond.
Celtic plc trades under the code CCPA on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Celtic plc (CCPA) trades on the London Exchange in UK. It last closed at GBX 209.00 on 21 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 1,823 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.5% and over the last three months it fell 7.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -1.6% | ||
| From 52-week high | -16.7% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -7.9% | ||
| 6-month return | 10.0% | ||
| 12-month return, skipping the last month | 20.0% | ||
| Stability (higher is calmer) | 87 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 16.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.7% | ||
| Liquidity | 22 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.11M GBX | ||
| Zero-volume days | 55.0% | ||
| Income | 24 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −4.6% |
| 3 months | −7.9% |
| 6 months | +10.0% |
| 1 year | +14.5% |
| 3 years | +60.2% |
| 5 years | +70.8% |
Signals
| 50-day / 200-day average | 217.96 / 212.44 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.99 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Jul 2026 | GBP 0.0360 |
| 24 Jul 2025 | GBP 0.0360 |
| 25 Jul 2024 | GBP 0.0360 |
| 27 Jul 2023 | GBP 0.0360 |
| 28 Jul 2022 | GBP 0.0360 |
| 29 Jul 2021 | GBP 0.0360 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.